Blood pressure

Bloomlife and Valley Perinatal Services Partner to Transform High-Risk Maternal Care

Retrieved on: 
Tuesday, March 5, 2024
Blood pressure, SAN, Pregnancy, Conference, Society, Hypertension, Health, Disease, Patient, Mortality, VPS, Partnership, Birth control

SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Bloomlife, an award winning women's health company, and Valley Perinatal Services (VPS), Arizona's leading high-risk maternal fetal medicine group, today announced a commercial partnership along with results from the initial deployment of Bloomlife's remote maternal care platform Bloomlife Connects.

Key Points: 
  • SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Bloomlife, an award winning women's health company, and Valley Perinatal Services (VPS), Arizona's leading high-risk maternal fetal medicine group, today announced a commercial partnership along with results from the initial deployment of Bloomlife's remote maternal care platform Bloomlife Connects.
  • With an initial focus on hypertension, Bloomlife Connects offered VPS a simple way to connect mom and doctor between checkups.
  • Current approaches to managing this disease put an enormous burden on both patients and providers," says Ravi Gunatilake, Medical Director at Valley Perinatal Services.
  • To validate the impact of Bloomlife's remote maternal care offering, VPS and Bloomlife ran a study comparing patients enrolled in Bloomlife Connects to those following standard-of-care.

Tampa General Hospital Brings New Hope for Patients with Advanced Blood Cancers

Retrieved on: 
Monday, March 4, 2024
Bone marrow, Blood pressure, Liver, Multiple myeloma, EVP, B-cell lymphoma, Immunotherapy, NHL, Borrello, Temperature, FDA, Physician, Food, Cancer, Hospital, Heart rate, Tampa General Hospital, Cell, Skin, Cancer Institute, B cell, BMT, Ear, Breast, Home, Safety, Bacteria, Johns Hopkins, APRN, Virus, TGH, Leukemia, Non-Hodgkin lymphoma, Patient, Lymphoma, Protein, Tampa, Florida, Medicine, Otorhinolaryngology, Nose, DLBCL, Immune system, Pharmaceutical industry

TAMPA, Fla., March 4, 2024 /PRNewswire/ -- As part of its commitment to harness innovative advances in cancer care, the Tampa General Hospital (TGH) Cancer Institute has added a novel approach to its therapeutic armamentarium for the treatment of patients with aggressive forms of B-cell non-Hodgkin lymphomas and other types of blood cancers.

Key Points: 
  • The field of immunotherapy has evolved from an academic research program to an essential pillar in the treatment of many cancers.
  • All are intended for the treatment of blood cancers, including lymphomas, some forms of leukemia and, most recently, multiple myeloma.
  • Following comprehensive planning and discussion, Tampa General's Hospital at Home program has started to be applied to CAR T patients meeting certain criteria.
  • Due the benefit of remote monitoring, the TGH Cancer Institute and Hospital at Home teams have been working on adapting Hospital at Home for oncology patients.

Hanvon Technology Launches Groundbreaking Fourth-Generation BP Meter Based on Korotkoff Sound Method

Retrieved on: 
Thursday, February 29, 2024
BP, ISO, Blood pressure, Sphygmomanometer, Blood, Multimedia, Cardiovascular disease, Data collection, Approximation error, World Health Organization, Hypertension, Patient, NIBP, Diagnosis, Electronic, Mercury

BEIJING, Feb. 28, 2024 /PRNewswire/ -- Hanvon Technology Co., Ltd., based in China, has launched the world's first smart electronic BP Meter utilizing the Korotkoff sound method. This device integrates advanced sensor technology with artificial intelligence algorithms, overcomes the accuracy limitations of traditional electronic BP Meter, and achieves the precision of mercury sphygmomanometers; it starts a new era of Electronic BP Meters.

Key Points: 
  • BEIJING, Feb. 28, 2024 /PRNewswire/ -- Hanvon Technology Co., Ltd., based in China, has launched the world's first smart electronic BP Meter utilizing the Korotkoff sound method.
  • This device integrates advanced sensor technology with artificial intelligence algorithms, overcomes the accuracy limitations of traditional electronic BP Meter, and achieves the precision of mercury sphygmomanometers; it starts a new era of Electronic BP Meters.
  • The Korotkoff sound method, developed by Russian physician Nikolai Korotkoff in 1905.
  • Hanvon BP Meter with Korotkoff sound method is now available in China mainland, and is expected to enter the international market in the near future.

Cochlear calls for action in Washington D.C. ahead of World Hearing Day

Retrieved on: 
Wednesday, February 28, 2024
Blood pressure, Bangladesh Technical Education Board, Social isolation, Hearing, General Motors, Cochlear implant, Research, Greater Baltimore Medical Center, NIH, SVP, Quality of life, Ageing, Public health, Loneliness, Risk, Cochlear, World Hearing Day, Health, Hearing loss, Diplomatic mission, Policy, Patient, Family, Child, Speech, Development, Dentistry

WASHINGTON, Feb. 28, 2024 /PRNewswire/ -- Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D.C. ahead of World Hearing Day on Sunday March 3rd.

Key Points: 
  • WASHINGTON, Feb. 28, 2024 /PRNewswire/ -- Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D.C. ahead of World Hearing Day on Sunday March 3rd.
  • "After I took action and received my first cochlear implant in 1993, my life absolutely changed for the better."
  • Echoing Dr. Lin's education messaging, panelist Barbara Kelley, Executive Director of The Hearing Loss Association of America (HLAA) spoke about changing mindsets, urging Americans to protect hearing in noisy environments, check hearing with regular exams and treat hearing loss as soon as possible.
  • "If left unaddressed, hearing loss poses significant challenges to overall health and can be progressive, leading to greater hearing loss over time.

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management

Retrieved on: 
Tuesday, February 27, 2024
Blood pressure, USD, Entrepreneurship, Uber, Heart rate, Daniel, CHF, Verve, Death, Data, Khosla Ventures, Hypertension, Health, Deep learning, Research, Pharmaceutical industry

In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.

Key Points: 
  • In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.
  • Daniel, a seasoned technology executive with a distinguished career at companies like Uber and Google, brings a wealth of experience in entrepreneurship, product innovation, and scaling businesses.
  • His leadership will be instrumental in guiding Aktiia's strategic direction and expansion as the company continues to pioneer advancements in hypertension management.
  • "We are proud to have Daniel join our board and executive team," said Mattia Bertschi, CEO of Aktiia.

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management

Retrieved on: 
Tuesday, February 27, 2024
Blood pressure, USD, Entrepreneurship, Uber, Heart rate, Daniel, CHF, Verve, Death, Data, Khosla Ventures, Hypertension, Health, Deep learning, Research, Pharmaceutical industry

In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.

Key Points: 
  • In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.
  • Daniel, a seasoned technology executive with a distinguished career at companies like Uber and Google, brings a wealth of experience in entrepreneurship, product innovation, and scaling businesses.
  • His leadership will be instrumental in guiding Aktiia's strategic direction and expansion as the company continues to pioneer advancements in hypertension management.
  • "We are proud to have Daniel join our board and executive team," said Mattia Bertschi, CEO of Aktiia.

Vivacelle Bio Integrates Sub-Saharan Africa Strategy into Series B Financing Round

Retrieved on: 
Thursday, February 22, 2024
Blood pressure, Blood, School, Sepsis, Woman, IIA, Bleeding, Doctor of Philosophy, Resuscitation, The, Shock, MD, Diarrhea, Temperature, Septic, University, Nitric oxide, Shock (mechanics), Senior advisor, Finger, Life, Urinary tract infection, Risk, Internal bleeding, Pelvic floor dysfunction, Malaria, Hypovolemia, Nanoparticle, Gangrene, Neonatal sepsis, JD, Patient, Septic shock, Clinical trial, UMKC, Child, Reperfusion injury, Hypotension, Partnership

Targeted $20M Series B Round to include Sub-Saharan Africa in product development.

Key Points: 
  • Targeted $20M Series B Round to include Sub-Saharan Africa in product development.
  • Vivacelle Bio is partnering with Propelevate to drive the Sub-Saharan Africa strategy, which is fully integrated into its Series B financing round.
  • Through partnership with Propelevate, Vivacelle Bio will engage global health funders and stakeholders during final stages of product development, and Propelevate will drive Vivacelle Bio's go-to-market strategy for African markets upon regulatory approval.
  • "We are excited to partner with Vivacelle Bio because of their commitment to Sub-Saharan Africa.

Discover this new generic drug in the PERINDOPRIL range

Retrieved on: 
Wednesday, February 21, 2024
Blood pressure, Essential hypertension, Amlodipine, Quality of life, Health, Patient, Tablet, Perindopril, Ageing, Pharmaceutical industry

This oral treatment contains two medicines, perindopril arginine and amlodipine.

Key Points: 
  • This oral treatment contains two medicines, perindopril arginine and amlodipine.
  • They work together to control the blood pressure.
  • pms-PERINDOPRIL-AMLODIPINE are available in bottles of 100 tablets and comes in the following dosage forms:
    This medication is a generic equivalent of Viacoram MD1.
  • « Perindopril Amlodipine is manufactured in our Canadian facility which is another example of how we leverage our expertise and capabilities to deliver value to our customers and patients.

Black Health Matters Winter Health Summit and Expo Returns to Atlanta

Retrieved on: 
Wednesday, February 21, 2024
HCS, Blood pressure, Chronic kidney disease, Merck, Expo, Doctor of Philosophy, BHM, Anemia, Courage, Professor, Lunch, Conditional sentence, Amgen, Cholesterol, Blood, Obesity, DD, Conference, Health, Boehringer Ingelheim, STD, Maternal health, BMI, Lilly, JD, Radio, PSA, WAOK, Guru, Health equity, FREE, Interior design

NEW YORK, Feb. 21, 2024 /PRNewswire/ -- Following an incredibly successful inaugural event in 2023, Black Health Matters (BHM) is once more bringing its celebrated health summit series to Atlanta. On Saturday, March 2nd, 2024, the Black Health Matters Winter Health Summit & Expo will be held at the downtown Atlanta Loudermilk Conference Center, 40 Courtland St. N.E., from 8:30 AM to 4:00 PM EST. This FREE, hybrid (in-person and virtual) event will offer attendees a singular wellness experience, connecting dynamic experts on chronic illness and healthiness, patient advocates and celebrity guests with the public. Those who attend will benefit from free health screenings and immunizations, presentations on chronic disease management, invigorating fitness sessions, entertainment and more. Complimentary breakfast, lunch and parking will be offered, along with FREE giveaways and prizes. To register go to www.bhm2024wintersummit.com for in-person or virtual attendance.

Key Points: 
  • Theme is "Inspiration for Your Mind, Body and Soul"
    NEW YORK, Feb. 21, 2024 /PRNewswire/ -- Following an incredibly successful inaugural event in 2023, Black Health Matters (BHM) is once more bringing its celebrated health summit series to Atlanta.
  • On Saturday, March 2nd, 2024, the Black Health Matters Winter Health Summit & Expo will be held at the downtown Atlanta Loudermilk Conference Center, 40 Courtland St.
  • "The Winter Health Summit and Expo can be your ally on your path to better health and wellness," says Roslyn Young Daniels, founder, and president of Black Health Matters.
  • The Black Health Matters Winter Summit & Expo's impressive list of sponsors includes Amgen, Boehringer Ingelheim, Johnson & Johnson HCS Advocacy, Johnson & Johnson Innovative Medicine Clinical Trials, Lilly, Merck, Pfizer, and Vertex.

Healthy Foods Deliver Defense Against Cancer and Heart Disease

Retrieved on: 
Wednesday, February 21, 2024
Buffalo, Blood pressure, Diabetes, Breast cancer, Consumer, Effect, Copper, Research, Magnesium, Zinc, Cholesterol, Blood, Obesity, Mineral, Food, Vitamin, Weight loss, Glycemic, Prostate, Plant, Harvard University, Purdue University, Conditional sentence, Exercise, Plaque, Human body weight, Phytosterol, Niacin, Risk, Potassium, Vitamin E, Seed, Types of plant oils, Radiation, Olive oil, Health, Folate, University, Death, Nutrient, Fasting, Medicine, Artery, Physiology, Heart, Resveratrol, Food industry, Pinterest, Meal, Brain, Fats, HDL, Cancer, Randomized controlled trial, Dietary supplement

The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.

Key Points: 
  • The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.
  • According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, followed by cancer.
  • There are a number of factors that can increase the risk of developing heart disease, including high blood pressure, high cholesterol, obesity and diabetes .
  • Research shows that in addition to inhibiting colon, prostate and breast cancer cell growth, they can also protect against heart disease.